Application of QbD Principles for the Evaluation of Empty Hard Capsules as an Input Parameter in Formulation Development and Manufacturing
Understanding the product and process variable on the final product performance is an essential part of the quality-by-design (QbD) principles in pharmaceutical development. The hard capsule is an established pharmaceutical dosage form used worldwide in development and manufacturing. The empty hard capsules are supplied as an excipient that is filled by pharmaceutical manufacturers with a variety of different formulations and products. To understand the potential variations of the empty hard capsules as an input parameter and its potential impact on the finished product quality, a study was performed investigating the critical quality parameters within and in between different batches of empty hard gelatin capsules. The variability of the hard capsules showed high consistency within the specification of the critical quality parameters. This also accounts for the disintegration times, when automatic endpoint detection was used. Based on these data, hard capsules can be considered as a suitable excipient for product development using QbD principles.
- Almukainz M, Salehi M, Araci Bou-Chacra N, Lobenberg R. Investigation of the performance of the disintegration test for dietary supplements. AAPS J. 2010;12:602–7. CrossRef
- Cadé D, Madit N. Liquid filling in hard gelatin capsules—preliminary steps. Bull Technol Gattefosse. 1996;89:15–21.
- Donauer N, Lobenberg R. A mini review of scientific and pharmacopeial requirements for the disintegration test. Int J Pharm. 2007;345:2–8. CrossRef
- EMA-FDA pilot program for parallel assessment of Quality-by-Design applications: lessons learnt and Q&A resulting from the first parallel assessment. EMA/430501/2013. August 20, 2013
- Garcia T, Cook G, Nosal R. PQLI Key topics—criticality, design space, and control strategy. J Pharm Innov. 2008;3:60–8. CrossRef
- Lebert I, Dussap CG, Lebert A. Effect of aw, controlled by the addition of solutes or by water content, on the growth of Listeria innocua in broth and in a gelatin model. Int J Food Microbiol. 2004;94:67–78. CrossRef
- Ludwig A, Van Ooteghem M, Delva A. Disintegration of hard gelatin capsules. Part 1: composition and structure of the capsule wall. Pharm Ind. 1979;41:769–98.
- Ludwig A, Van Ooteghem M. Disintegration of hard gelatin capsules. Part 2: disintegration mechanism of hard gelatin capsules investigated with a stereoscopic microscope. Pharm Ind. 1980;42:405–6.
- McCurdy V, am Ende MT, Busch FR, Mustakis J, Rose P, Berry MR. Quality by Design using an integrated active pharmaceutical ingredient – drug product approach to development. Pharm. Engineer. 2010;4:12–32.
- Nolan DA, Chamblin DC, Troller JA. Minimal water activity levels for growth and survival of Listeria monocytogenes and Listeria innocua. Int J Food Microbiol. 1992;16:323–35. CrossRef
- Theys TE, Geeraerd AH, Devlieghere F, Van Impe JF. Extracting information on the evolution of living- and dead cell fractions of Salmonella Typhimurium colonies in gelatin gels based on microscopic images and plate-count data. Lett Appl Microbiol. 2009;49:39–45. CrossRef
- Theys TE, Geeraerd AH, Devlieghere F, Van Impe JF. On the selection of relevant environmental factors to predict microbial dynamics in solidified media. Food Microbiol. 2010;27:220–8. CrossRef
- Woodcock J. The concept of pharmaceutical quality. Am Pharm Rev. 2004;6:10–5.
- Yu LX. Pharmaceutical Quality by Design: product and process development, understanding, and control. Pharm Res. 2008;25:781–91. CrossRef
- Application of QbD Principles for the Evaluation of Empty Hard Capsules as an Input Parameter in Formulation Development and Manufacturing
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Volume 15, Issue 3 , pp 542-549
- Cover Date
- Online ISSN
- Springer US
- Additional Links
- capsule development
- capsule specification
- hard capsules
- Industry Sectors
- Author Affiliations
- 1. Capsugel, Rijksweg 11, 2880, Bornem, Belgium
- 2. GlaxoSmithKline, New Frontier Science Park, Third Avenue, Harlow, CM195AW, UK
- 3. Capsugel, Rue Timken 10, 68000, Colmar, France
- 4. Research Center Pharmaceutical Engineering, Inffeldgasse 13, 8010, Graz, Austria